A detailed history of Cerity Partners LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Cerity Partners LLC holds 84,998 shares of BDX stock, worth $19.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
84,998
Previous 67,554 25.82%
Holding current value
$19.7 Million
Previous $15.8 Million 29.8%
% of portfolio
0.05%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$221.47 - $242.41 $3.86 Million - $4.23 Million
17,444 Added 25.82%
84,998 $20.5 Million
Q2 2024

Aug 13, 2024

SELL
$225.07 - $246.17 $4.1 Million - $4.49 Million
-18,235 Reduced 21.26%
67,554 $15.8 Million
Q1 2024

May 14, 2024

BUY
$233.45 - $247.73 $6.69 Million - $7.1 Million
28,652 Added 50.15%
85,789 $21.2 Million
Q4 2023

Jan 26, 2024

BUY
$232.24 - $267.23 $5 Million - $5.75 Million
21,531 Added 60.47%
57,137 $13.9 Million
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $5.93 Million - $6.6 Million
-23,256 Reduced 39.51%
35,606 $9.21 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $366,882 - $408,327
-1,539 Reduced 2.55%
58,862 $15.5 Million
Q1 2023

May 11, 2023

BUY
$229.71 - $259.35 $4.34 Million - $4.9 Million
18,907 Added 45.57%
60,401 $15 Million
Q4 2022

Feb 15, 2023

BUY
$218.29 - $256.91 $2.69 Million - $3.16 Million
12,305 Added 42.16%
41,494 $10.6 Million
Q3 2022

Nov 10, 2022

SELL
$51.03 - $264.23 $127,166 - $658,461
-2,492 Reduced 7.87%
29,189 $6.51 Million
Q2 2022

Aug 10, 2022

BUY
$234.74 - $275.42 $3.56 Million - $4.18 Million
15,164 Added 91.81%
31,681 $7.81 Million
Q1 2022

Apr 25, 2022

BUY
$243.64 - $270.48 $716,057 - $794,940
2,939 Added 21.65%
16,517 $3.96 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $608,561 - $663,736
2,645 Added 24.19%
13,578 $3.42 Million
Q3 2021

Oct 25, 2021

SELL
$232.72 - $256.47 $356,061 - $392,399
-1,530 Reduced 12.28%
10,933 $2.69 Million
Q2 2021

Aug 11, 2021

SELL
$232.65 - $254.58 $1.92 Million - $2.11 Million
-8,271 Reduced 39.89%
12,463 $3.03 Million
Q1 2021

Aug 11, 2021

SELL
$232.09 - $256.88 $15,782 - $17,467
-68 Reduced 0.33%
20,734 $5.04 Million
Q1 2021

May 12, 2021

SELL
$232.09 - $256.88 $51,756 - $57,284
-223 Reduced 1.06%
20,802 $5.06 Million
Q4 2020

Feb 11, 2021

SELL
$221.92 - $245.94 $51,041 - $56,566
-230 Reduced 1.08%
21,025 $5.26 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $3.71 Million - $4.75 Million
17,175 Added 420.96%
21,255 $4.94 Million
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $178,998 - $214,415
-814 Reduced 16.63%
4,080 $976,000
Q1 2020

May 14, 2020

BUY
$195.69 - $279.01 $177,295 - $252,783
906 Added 22.72%
4,894 $1.13 Million
Q4 2019

Feb 14, 2020

SELL
$236.45 - $266.82 $810,314 - $914,392
-3,427 Reduced 46.22%
3,988 $1.09 Million
Q3 2019

Oct 30, 2019

SELL
$230.58 - $256.08 $41,043 - $45,582
-178 Reduced 2.34%
7,415 $1.88 Million
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $1.51 Million - $1.71 Million
-6,967 Reduced 47.85%
7,593 $1.91 Million
Q1 2019

May 14, 2019

SELL
$206.05 - $248.17 $663,893 - $799,603
-3,222 Reduced 18.12%
14,560 $3.64 Million
Q4 2018

Feb 06, 2019

BUY
$204.73 - $257.93 $644,490 - $811,963
3,148 Added 21.51%
17,782 $4.01 Million
Q3 2018

Nov 15, 2018

BUY
$233.07 - $256.0 $75,281 - $82,688
323 Added 2.26%
14,634 $3.82 Million
Q2 2018

Aug 15, 2018

SELL
$208.1 - $233.85 $113,414 - $127,448
-545 Reduced 3.67%
14,311 $3.43 Million
Q1 2018

May 15, 2018

BUY
$205.46 - $240.27 $965,045 - $1.13 Million
4,697 Added 46.23%
14,856 $3.22 Million
Q4 2017

Feb 14, 2018

BUY
$189.0 - $222.64 $989,982 - $1.17 Million
5,238 Added 106.44%
10,159 $2.18 Million
Q3 2017

Nov 13, 2017

BUY
$186.89 - $198.9 $919,685 - $978,786
4,921
4,921 $964,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.